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Bacteriophages (phages) are viruses of bacteria. Here we evaluated the effects of T4 and
A3/R bacteriophages, as well as phage-generated bacterial lysates, on differentiation of
human myeloid dendritic cells (DCs) from monocytes. Neither of the phages significantly
reduced the expression of markers associated with differentiation of DCs and their role
in the activation of T cells (CD40, CD80, CD83, CD86, CD1c, CD11c, MHC II, PD-L1,
PD-L2, TLR2, TLR4, and CCR7) and phagocytosis receptors (CD64 and DEC-205).
By contrast, bacterial lysate of T4 phage significantly decreased the percentages of
DEC-205- and CD1c-positive cells. The percentage of DEC-205-positive cells was also
significantly reduced in DCs differentiated in the presence of lysate of A3/R phage. Thus
while bacteriophages do not substantially affect differentiation of DCs, some products
of phage-induced lysis of bacterial cells may influence the differentiation and potentially
also some functions of DCs. Our results have important implications for phage therapy
of bacterial infections because during infections monocytes recruited to the site of
inflammation are an important source of inflammatory DCs.
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INTRODUCTION
Bacteriophages (phages) are viruses of bacteria. Phages constitute an extremely abundant and
diversified group of viruses. Thus far, over 6000 bacteriophages have been identified by using
electron microscopy and the total number of phage virions in the biosphere has been estimated
at around 1032. Phages occur in great numbers in different environments including water, soil,
and air. Moreover they are an important component of the microflora in humans and different
animals (Letarov and Kulikov, 2009; Hatfull and Hendrix, 2011; Ackermann and Prangishvili,
2012; Dalmasso et al., 2014). The main biomedical application of bacteriophages is the treatment of
bacterial infections; many studies performed on animal models of infections, observational clinical
studies, and the first small randomized controlled trials of phage therapy indicate high safety and
efficacy of phages as antibacterial agents (Kutter et al., 2014; Wittebole et al., 2014). In addition,
a growing body of data shows that bacteriophages can affect functions of different populations of
immune cells involved in both innate and adaptive immunity including neutrophils, monocytes,
macrophages, as well as T and B cells (Borysowski et al., 2010; Górski et al., 2012).
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An important population of immune cells critically involved
in the regulation of immune responses are dendritic cells (DCs).
DCs present antigens to lymphocytes, priming naïve T cells
and driving them toward a specific lineage fate. The maturation
state of DCs can be manipulated to boost or suppress immune
responses. Several DC subpopulations have been identified based
on typical surface molecule expression patterns. Each DC subset
possesses unique functional specialization. The major population
of human myeloid DCs (mDCs) in blood, tissues and lymphoid
organs are CD1c+ mDCs. They were originally identified in
blood as a fraction of HLA-DR+ lineage cells expressing myeloid
antigens CD11b, CD11c, CD13, CD33, CD172a (SIRP α) and
CD45RO. Human tissue CD1c+ DCs tend to be more activated
than their blood counterparts in terms of expression of CD80,
CD83, CD86 and CD40. They have lost expression of homing
receptors CLA and CD62L but up-regulated CCR7. CD1c+ DCs
are equipped with a wide range of lectins, Toll-like receptors
(TLRs) and other pattern recognition receptors (PRRs) involved
in antigen uptake, transport and presentation (Collin et al., 2013;
McGovern et al., 2015; Poltorak and Schraml, 2015; Vu Manh
et al., 2015).
Given the central role of DCs in the regulation of immune
responses, research on the interactions between phages and DCs
is essential for understanding the effects of bacterial viruses on
the immune system. Over recent years the first studies have
been conducted to investigate the influence of bacteriophages on
some functions of DCs (Pajtasz-Piasecka et al., 2008; Sartorius
et al., 2011; Miernikiewicz et al., 2013; An et al., 2014). All
these studies were performed on murine bone marrow-derived
dendritic cells (BMDCs); to the best of our knowledge, there are
no data on the interactions between phages and human DCs. The
results of studies of murine DCs cannot be simply extrapolated to
human DCs because of substantial differences between functions
of murine and human DCs; these differences pertain to the
production of some cytokines, the expression of some surface
molecules including TLRs, and the effects of viral stimulation
(Robbins et al., 2008; Schlitzer et al., 2015). Therefore, in this
study we asked whether bacteriophages can affect human DCs.
The main objective of this study was to evaluate the effects
of two bacteriophages – T4 (specific for Escherichia coli) and
A3/R (specific for Staphylococcus aureus) on the differentiation
of human mDCs from monocytes in vitro. Moreover, we
investigated whether mDCs differentiation can be affected by the
products of phage-induced lysis of host bacteria.
MATERIALS AND METHODS
Bacteriophages
T4 phage was purchased from American Type Culture Collection
(ATCC; USA) and was cultured on E. coli B obtained from
the Collection of Microorganisms of the L. Hirszfeld Institute
of Immunology and Experimental Therapy (IIET), Wrocław,
Poland.
A3/R was obtained from the Phage Collection of IIET. It is
a descendant of A3 phage which was originally obtained from
Gerhard Pulverer, Institute of Hygiene, University of Cologne,
Germany in 1986, and adapted to therapeutic use by several
rounds of passaging through clinical S. aureus strains. A3/R
was cultured on S. aureus strain 19930 from Laboratory of
Bacteriophages, IIET.
Purified preparation of T4 phage was prepared by Laboratory
of Bacteriophages, IIET, as described in detail elsewhere
(Boratyn´ski et al., 2004). In brief, the protocol involves
sequential ultrafiltration of crude phage-generated E. coli lysate
through polysulfone membranes followed by chromatography
on sepharose 4B (Sigma-Aldrich, Poland) and cellulofine sulfate
(Millipore, USA). To obtain purified preparation of A/3R, crude
phage-generated S. aureus lysate was subjected to ultrafiltration
through polysulfone membranes and chromatography on
sepharose 4B. Stock phage preparations were suspended in
phosphate-buffered saline (PBS). Phage titer was measured by
two-layer method of Adams (1959). The concentration of LPS
in purified phage preparations was determined using QLC-
1000 Endpoint Chromogenic LAL test kit (Lonza) according
to the manufacturer’s instructions. In the A3/R preparation
the concentration of LPS was undetectable, while in the T4
phage preparation it was 3 ng/ml. Therefore, as an additional
control for T4 phage, LPS (Sigma-Aldrich, Poland) was used at
a concentration of 3 ng/ml. LPS was diluted with PBS.
Bacterial Lysates
Phage-generated bacterial lysates were prepared by Laboratory
of Bacteriophages, IIET, according to the modified method by
Slopek et al. (1983; Letkiewicz et al., 2009). In brief, phages were
incubated with their host bacteria in LB medium at 37◦C until
complete bacterial lysis occurred (approx. 4–6 h). Subsequently
the suspension was filtered through a 0.22-µm filter (Millipore,
USA). Stock preparations of both lysates were suspended in
peptone water (IIET, Poland). Phage titer in lysates was measured
by two-layer method of Adams (1959).
As an additional control in experiments to evaluate the effects
of lysates on differentiation of DCs peptone water was used.
Generation of Myeloid Dendritic Cells
from Peripheral Blood Monocytes
The study was performed on cells isolated from healthy blood
donors. Informed, written consent was obtained from all donors
and the study was approved by the ethical committee of the
Medical University of Warsaw. Peripheral blood mononuclear
cells (PBMCs) were isolated from blood specimens by density-
gradient centrifugation over Gradisol L (Aqua Medica, Łódz´,
Poland). Isolation of monocytes from PBMCs was performed
using Dynabeads R© FlowCompTM Human CD14 (Invitrogen)
according to the manufacturer’s instructions. The purity
of monocyte population was evaluated by flow cytometry
(FACSCalibur, Becton Dickinson) using anti-CD14 monoclonal
antibody (BD Pharmingen). The purity of the isolated monocytes
was 98%. Monocytes were cultured at a density of 1 × 106/ml in
the AIM-V medium (Gibco) supplemented with IL-4 (100 ng/ml;
R&D Systems) and GM-CSF (250 ng/ml; R&D Systems) in
24-well plates at 37◦C with 5% CO2 for 5 days. In some
cultures purified phage preparations or bacterial lysates were
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added on day 0 to wells at a density of 108 PFU/ml (final
concentration). In control cultures, equal volumes of PBS were
added to wells. Differentiation of monocytes into mDCs was
evaluated by flow cytometry (FACSCalibur, Becton Dickinson)
using the following monoclonal antibodies: anti-CD11c-APC
(BD Pharmingen), anti-CD1c-FITC (eBioscience), anti-CCR7-
APC-e Fluor (eBioscience). In addition, cells were stained with
anti-CD14-PerCP (BD Pharmingen) to confirm the state of
differentiation of DCs which lose CD14 during differentiation.
We consistently found that the percentage of CD14 cells in
cultures was 98%. In addition, cell morphology during DCs
differentiation was analyzed using ECLIPSE TE200 inverted
microscope (Nikon) with a digital camera and the NIS-Elements
software. On the last day of culture viability of DCs was
determined using trypan blue. The viability of cells was 95%.
Cultured cells were photographed and the expression of the
investigated markers was determined by flow cytometry.
Evaluation of Expression of mDCs
Surface Markers
Cells were incubated with appropriate monoclonal anti-
bodies: CD11c-APCw (BD Pharmingen), CD1c-FITC
(eBioscience), CD83-PE (BD Pharmingen), CD80-FITC
(BD Pharmingen), CD86-PE (BD Pharmingen), CD40-PE (BD
Pharmingen), PD-L1-FITC (BD Pharmingen), PD-L2-PE (BD
Pharmingen), HLA-DR-PE (BD Pharmingen), CCR7-APC-e
Fluor (eBioscience), TLR2-FITC (eBioscience), TLR4-PE
(eBioscience), CD64-FITC (BD Pharmingen), and DEC-205-PE
(BD Pharmingen). In addition, CD14-PerCP (BD Pharmingen)
monoclonal antibody was used to confirm the differentiation
of DCs. Isotype controls were cells stained with IgG1
conjugated with the respective fluorochromes (BD Pharmingen,
eBioscience). After 30 min of incubation at 4◦C, cells were
washed twice in FACS buffer (Becton Dickinson). The expression
of individual markers on gated CD1c+ DCs was determined by
flow cytometry (FACSCalibur, Becton Dickinson) and analyzed
by Cell Quest software (Becton Dickinson). The results were
based on analysis of at least 100,000 cells and were shown as
the percentage of positively labeled cells. In addition, the mean
channel fluorescence values of gated DCs positive for individual
markers were determined.
Determination of Cytokine Production
The concentration of IL-12 (p70) was measured in cell culture
supernatants by enzyme-linked immunoassay (ELISA) using
Human IL-12 p70 ELISA Ready-SET-Go kit according to the
manufacturer’s instructions (eBioscience).
Statistics
Statistical analysis was performed by Wilcoxon’s matched pairs
test. P < 0.05 was regarded as significant.
RESULTS
To evaluate the effects of T4 and A3/R phages on the
differentiation of mDCs, we analyzed the expression of main
DC markers on mDCs differentiated from monocytes in the
presence of individual preparations. We focused on two classes
of markers: (i) molecules associated with maturation of DCs and
their role in the activation of T cells (CD40, CD80, CD83, CD86,
CD1c, CD11c, MHC class II, PD-L1, PD-L2, TLR2, TLR4, and
CCR7), and (ii) receptors involved in phagocytosis (CD64 and
DEC-205). In each case, we determined both the percentage of
mDCs expressing a given marker and the value of the mean
channel fluorescence of gated mDCs positive for this marker.
In general, both T4 and A3/R phage had no effect on
the expression of any of the investigated markers. The
percentages of cells expressing individual markers associated
with differentiation of DCs and their role in the activation of
T cells were comparable in mDCs generated in the presence
of bacteriophages and in control cultures (Figure 1). Of note,
we found some interpersonal variability in the level of CD80
expression compared with the level of expression of other
analyzed markers.
Likewise, bacteriophages had no effect on the percentages of
CD64- and DEC-205-positive mDCs (Figure 2). In addition, we
found no significant differences between the expression of the
analyzed markers on cells cultured in the presence of LPS (an
additional control for T4 phage) and cells from control cultures
(treated with PBS; data not shown).
In addition, we found no significant differences in the mean
channel fluorescence values for the analyzed markers between
mDCs differentiated in the presence of phages and in control
cultures (Table 1).
Moreover, we did not observe any visible changes in
morphology of mDCs generated in cultures to which phages were
added compared with control cultures; in particular, we found no
reduction in the number of cells with long dendrites, a hallmark
of typical DC morphology (Figure 3).
Unlike purified bacteriophage preparations, phage-generated
bacterial lysates affected the expression of some of the
investigated markers. First, the percentages of DEC-205-
and CD1c-positive cells were significantly reduced in mDCs
differentiated in the presence of lysate of E. coli compared
with mDCs from control cultures (p = 0.001 and p = 0.002,
respectively; Figures 1, 2, and 4). Moreover, the percentages of
TLR4- and PD-L2-positive mDCs were significantly higher in
cultures to which the lysate was added compared with control
cultures (p = 0.012 and p = 0.018, respectively; Figures 1
and 4); however, no significant difference was observed in the
percentages of TLR4- and PD-L2-positive cells between mDCs
generated in the presence of the lysate compared with mDCs
differentiated in the presence of peptone water (data not shown).
We also found that in mDCs differentiated in the presence of
lysate of S. aureus the percentage of DEC-205-positive cells was
significantly reduced compared with mDCs from control cultures
(p= 0.016; Figures 2 and 4). However, neither of the investigated
lysates significantly affected the mean channel fluorescence values
for individual markers (Table 1).
Representative density plots for markers for which statistically
significant differences were found between mDC differentiated
in the presence of lysates and mDCs from control cultures are
shown in Figure 4.
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FIGURE 1 | The effects of bacteriophages and bacteriophage-generated bacterial lysates on the expression of markers associated with the
differentiation of myeloid dendritic cells and their role in T cell activation. Human myeloid dendritic cells (mDCs) were differentiated from monocytes during
five-day cultures with IL-4 (100 ng/ml) and GM-CSF (250 ng/ml) in the presence of individual phage preparations including purified preparation of T4 (white bars, ),
T4-generated Escherichia coli lysate (white bars, ), purified preparation of A3/R (gray bars, ), or A3/R-generated Staphylococcus aureus lysate (gray bars, ). In
control cultures cells were treated with equal volumes of PBS. The expression of all markers including CD40, CD80, CD83, CD86, CD1c, CD11c, MHC class II,
PD-L1, PD-L2, TLR2, TLR4, and CCR7 was determined by flow cytometry. The bars show the percentages of mDCs expressing individual markers. The experiment
was repeated five times. *p < 0.05.
FIGURE 2 | The influence of bacteriophages and bacteriophage-generated bacterial lysates on the expression on myeloid dendritic cells of receptors
involved in phagocytosis. Human mDCs were differentiated from monocytes during five-day cultures with IL-4 (100 ng/ml) and GM-CSF (250 ng/ml) in the
presence of individual phage preparations including purified preparation of T4 (white bars, ), T4-generated Escherichia coli lysate (white bars, ), purified
preparation of A3/R (gray bars, ), or A3/R-generated Staphylococcus aureus lysate (gray bars, ). In control cultures cells were treated with equal volumes of
PBS. The expression on mDCs of DEC-205 and CD64 molecules was determined by flow cytometry. The bars show the percentages of mDCs expressing DEC-205
and CD64. The experiment was repeated five times. ∗p < 0.05.
We also observed that both lysates significantly reduced the
number of cells with typical DC morphology (long dendrites)
compared to control cultures (Figure 3).
Apart from the expression of main DC markers, we also
investigated the production by mDCs of IL-12 p70. However, the
level of IL-12 was undetectable in culture supernatants of mDCs
generated in the presence of both purified phage preparations and
lysates of E. coli and S. aureus, as well as in control cultures (data
not shown).
DISCUSSION
The overall objective of this study was to evaluate the effects of T4
and A3/R bacteriophages on the differentiation of human mDCs
from monocytes. In in vivo settings phages may affect function of
immune cells not only by direct interactions, but also indirectly,
by different components of bacterial cells released from lysed
bacteria. Therefore, our study included experiments to investigate
both direct effects of bacteriophage particles on mDCs and the
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TABLE 1 | Geo mean values of surface markers of mDCs differentiated in the presence of bacteriophages and bacteriophage-generated bacterial
lysates.
Control phage bacterial lysate
Geo Mean T4 A3/R T4 A3/R Escherichia coli
(T4)
Staphylococcus
aureus (A3/R)
CD1c 23.2 (± 4.3) 24.7 (± 9.5) 23.6 (± 4.2) 24.8 (± 7.7) 20.6 (± 3.5) 22.8 (± 4.7)
CD11c 182.5 (± 67.3) 134.4 (± 36.3) 140.5 (± 38.5) 119.7 (± 32.4) 111.3 (± 23.3) 137.6 (± 35.4)
MHCII 77.2 (± 34) 50.2 (± 17.5) 70 (± 9.5) 47.6(18.5) 60.2 (± 14.9) 47.3 (± 8.1)
CCR7 36.3 (± 3.2) 46.4 (± 22.8) 35.8 (± 14.1) 58.8 (± 30.7) 50.3 (± 31.7) 43.8 (± 20.3)
CD86 62.5 (± 14.1) 63.8 (± 12.5) 65 (± 10.4) 67 (± 13.4) 57.8 (± 4.3) 57 (± 12.9)
CD80 51.6 (± 5.4) 57.8 (± 9.1) 47.8 (± 5.1) 60 (± 5.5) 59.2 (± 4.4) 44.2 (± 7)
CD40 29 (± 2.3) 28.7 (± 2.3) 25.6 (± 4.2) 26.4 (± 2) 25.6 (± 4.5) 28 (± 0.8)
CD83 18.4 (± 1.1) 20.7 (± 5.6) 18.2 (± 1.8) 20.5 (± 6.3) 18.4 (± 1.1) 21 (± 6.4)
TLR2 16.2 (± 1.8) 16.2 (± 1.6) 19.2 (± 3) 18.4 (± 3.6) 21.4 (± 6) 17 (± 1.2)
TLR4 29.3 (± 2.3) 28.4 (± 2.3) 33.7 (± 7) 29.2 (± 4.8) 31.8 (± 5.7) 33.8 (± 6.7)
PD-L1 25 (± 4.5) 23 (± 3.4) 22.6 (± 2.1) 23.4 (± 2.9) 29.4 (± 4.7) 29 (± 3.6)
PD-L2 17.4 (± 4.6) 17.4 (± 3.4) 17.4 (± 4.9) 18.6 (± 5.2) 21.8 (± 4.6) 18.8 (± 5.1)
DEC-205 42.8 (± 15.6) 42.8 (± 11.2) 41.2 (± 9.8) 46.4 (± 10.8) 53 (± 18.7) 36 (± 2.4)
CD64 29.8 (± 7) 29.9 (± 5.7) 24.7 (± 6.7) 22.6 (± 2.6) 22.8 (± 6.4) 23.3 (± 3.4)
influence of phage-generated bacterial lysates. Such lysates are
also used in the treatment of bacterial infections at some centers
of phage therapy (Mie˛dzybrodzki et al., 2012).
As model phages we employed T4 and A3/R. T4 is a classic
phage that has been extensively characterized at the genetic and
molecular level (Leiman et al., 2003). It belongs to the T4-
like viruses genus of the Tevenvirinae subfamily of Myoviridae
(Adriaenssens et al., 2012). Its dsDNA genome is 168 kb long
and contains 278 open reading frames (ORFs) (Miller et al.,
2003; Petrov et al., 2010). A3/R is a novel bacteriophage that
was described recently (Łobocka et al., 2012). It is a strictly lytic,
polyvalent staphylococcal phage from the Twort-like genus of the
Spounavirinae subfamily of myoviruses. The dsDNA genome of
A3/R is 132 kb long and contains 196 ORFs (GenBank Acc. No.
JX080301).
We found that both the percentages of cells expressing
individual markers and the mean channel fluorescence values for
these markers were similar in mDCs generated in the presence
of phages and in control cultures. These results indicate that T4
and A3/R do not adversely affect the differentiation of mDCs
and the expression of molecules essential for some of DCs’ main
functions, especially a role in T cell activation and phagocytosis.
The data obtained for T4 bacteriophage are in line with the results
of Miernikiewicz et al. (2013) who showed that this phage does
not significantly affect the expression of CD40, CD80, CD86, and
MHC class II molecules on murine BMDCs in vitro. Likewise, in
the study by Pajtasz-Piasecka et al. (2008), incubation with T4 did
not substantially influence the expression of BMDC maturation
markers including CD80, CD86, CD40, CD54, as well as class I
and class II MHC. Potential effects on DCs of the other of the
investigated bacteriophages – A3/R – have not been evaluated
previously. In other studies, Cronobacter sakazakii ES2 phage
was found to increase the expression of CD40, CD86, and MHC
class II molecules on BMDCs (An et al., 2014), while filamentous
bacteriophage fd did not affect the expression of CD40, CD80,
CD86, MHC class I and MHC class II molecules on these cells
(Sartorius et al., 2011). Thus individual phages can exert different
effects on DCs.
It needs to be stressed that all previous studies on
the interactions between bacteriophages and DCs have been
conducted on BMDCs and their results cannot be simply
extrapolated to human DCs. This results from the fact that
there are substantial differences between murine and human DCs
(Robbins et al., 2008; Dutertre et al., 2014; Schlitzer et al., 2015).
To the best of our knowledge, our study is the first to evaluate
the effects of phages on human DCs. In addition, a panel of DC
markers analyzed in our study is considerably wider than the
panels used in previous studies. For example, our study is the
first to examine the effects of phages on the expression of some
molecules associated with differentiation of DCs and their role
in the activation of T cells (CD1c, CD11c, PD-L1, PD-L2, TLR2,
TLR4, and CCR7), as well as of phagocytosis receptors (CD64 and
DEC-205).
Recently, a specific subpopulation of DCs, called
inflammatory DCs (infDCs) was described (Serbina et al.,
2009; Segura and Amigorena, 2013; Dutertre et al., 2014;
Schlitzer et al., 2015). InfDCs are generated from monocytes
especially during inflammatory reactions (including those
accompanying infections). The differentiation of monocytes
into infDCs occurs at sites of ongoing inflammation. Thus, a
finding that phages do not adversely affect the differentiation
of monocytes into mDCs in vitro suggests that bacterial viruses
should not inhibit the generation of infDCs in vivo; however, this
notion needs to be verified by further studies.
It is known that immature DCs do not produce IL-12; the
production of this cytokine is a feature of antigen-activated
mature DCs (Albrecht et al., 2008; Turnquist et al., 2010). Thus,
to evaluate whether bacteriophages can activate immature DCs,
we determined the production of IL-12 by mDCs generated
in the presence of T4 and A3/R. However, the level of
Frontiers in Microbiology | www.frontiersin.org 5 August 2016 | Volume 7 | Article 1267
fmicb-07-01267 August 13, 2016 Time: 17:44 # 6
Bocian et al. The Effects of Bacteriophages on Dendritic Cells
FIGURE 3 | Morphology of myeloid dendritic cells differentiated in the presence of bacteriophages and bacteriophage-generated bacterial lysates.
Human mDCs were differentiated from CD14+ monocytes during five-day cultures with IL-4 (100 ng/ml) and GM-CSF (250 ng/ml). The investigated preparations (T4
or A3/R bacteriophage, or the corresponding bacterial lysate) were added to wells on Day 0 of culture. In control cultures cells were treated with equal volumes of
PBS. In all culture variants cells have lost the expression of CD14 during differentiation (A). Morphology of mDCs differentiated in the presence of individual
preparations is shown at lower and higher resolution. White arrows indicate microbeads attached to cell surface (B). The presence of bacterial lysate of both T4 and
A3/R phage resulted in a reduction in the number of dendrites in differentiated mDCs compared with mDCs from control cultures and mDCs generated in the
presence of purified phage preparations (B,C).
IL-12 was undetectable in culture supernatants from mDCs
generated in the presence of bacteriophages, as well as in control
cultures. This confirms that phages do not activate immature
mDCs.
To evaluate whether the products of phage-induced lysis of
bacterial cells can affect DCs, we used unpurified E. coli and
S. aureus lysates generated in vitro as a result of infection of
bacteria by T4 and A3/R, respectively. Bacterial lysates appear
to be suitable model preparations for studying the effects of
products of phage-induced lysis of bacterial cells generated
in vivo. Moreover, investigating the effects of lysates is of
practical importance because such preparations are used at
some centers of phage therapy in the treatment of bacterial
infections (Mie˛dzybrodzki et al., 2012). We found that bacterial
lysate of T4 phage significantly decreased the percentages of
DEC-205- and CD1c-positive mDCs. The percentage of DEC-
205-positive cells was also significantly reduced in mDCs
generated in the presence of lysate of S. aureus, while the
expression of all other markers was unaffected. Remarkably,
neither of the studied lysates substantially affected the mean
channel fluorescence value for any marker. Furthermore, neither
of the lysates stimulated the production by mDCs of IL-
12.
DEC-205 (CD205) is a type I C-type lectin-like receptor
involved in antigen uptake, processing, and presentation.
Antigens endocytosed via DEC-205 were shown to enter both
MHC class I and MHC class II antigen presenting pathways and
to be consequently presented to both CD4+ and CD8+ T cells.
Recently DEC-205 was found to recognize ligands expressed
during apoptosis and necrosis by different cell populations, which
confirms a role of this receptor in the induction of both central
and peripheral tolerance to self-antigens (Shrimpton et al., 2009).
CD1c belongs to Group 1 CD molecules. Its main function is
the presentation of lipid antigens to different subpopulations
of T cells. Lipids presented by CD1c include sphingomyelin,
phosphatidylcholine, phosphatidylinositol, sulfatides, and
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FIGURE 4 | Representative results of analysis of the expression of surface markers of mDCs differentiated in the presence of
bacteriophage-generated bacterial lysates. Shown are representative density plots for markers for which statistically significant differences were found between
mDCs differentiated in the presence of bacterial lysates and mDCs from control cultures (treated with PBS). In addition, the figure shows representative density plots
for mDCs differentiated in the presence of bacteriophages. Anti-CD1c, anti-PD-L2, anti-TLR4, and anti-DEC-205 monoclonal antibodies were conjugated with
phycoerythrine (PE). Shown is also a representative density plot for isotype control (IgG-PE).
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acylated lipopeptides. CD1c was found to be capable of
presenting as antigens both endogenous lipids and some
components of Mycobacterium tuberculosis (Adams, 2014). It
should be noted that CD1c+ cells generated and investigated in
our study are more related to monocyte-derived cells than to bona
fide DCs (Guilliams et al., 2014).
Differences in the percentages of mDCs expressing CD1c and
DEC-205, as well as in morphology of differentiating DCs suggest
the presence in the lysate of T4 phage of factor(s) inhibiting
the differentiation of DCs from monocytes. These factor(s)
might inhibit DEC-205-mediated phagocytosis by DCs as well
as presentation of lipid antigens by CD1c. However, whether
the products of phage-induced lysis of bacterial cells can affect
functions of DCs mediated by these molecules should be verified
experimentally.
The presence of bacterial lysate of A3/R phage resulted in a
decrease in the percentage of DCs expressing DEC-205 (and thus
possessing a capacity for phagocytosis) and a lower number of
cells with typical DC morphology.
Given that the described changes in the expression of DC
markers were found only in cells cultured with phage-generated
bacterial lysates, and did not occur in cells treated with purified
bacteriophages, it is apparent that they were caused not by phage
virions themselves, but rather by some components of bacterial
cells present in the lysates. These results indicate that some
products of phage-induced lysis of bacteria also could affect
function of DCs in vivo. However, at this stage of our research
we wanted to evaluate whether bacteriophage-generated bacterial
lysates can have any effect on the differentiation of DCs. Further
studies should be conducted to identify the component(s) of
lysates that affect the expression of mDCs markers. Given that
some significant changes in the expression of mDCs markers
(as well as in morphology of mDCs) were induced also by
S. aureus lysate, it is unlikely that LPS was the sole bacterial
component responsible for these effects. Apart from LPS (present
in E. coli lysate) also other bacterial components could influence
the differentiation of DCs.
The interactions between the products of the phage-induced
lysis of bacteria and immune cells might be important especially
in the gut where phages are present in very large numbers
and constitute the primary factor to regulate the growth of
the microbiota (Letarov and Kulikov, 2009; Mills et al., 2013;
Dalmasso et al., 2014). Lysis of bacterial cells can also occur in
patients with bacterial infections treated with phage preparations.
In fact, phage therapy is currently considered one of the most
promising ways of treatment of antibiotic-resistant infections
(Kutter et al., 2014; Wittebole et al., 2014).
The present study focused on the first stage of the development
of DCs, that is the differentiation of immature DCs from
monocytes. To extend knowledge on the interactions between
phages and DCs, studies should be performed to evaluate
the effects of phage preparations on further stages of DCs
development, in particular their maturation and function of
mature DCs, especially their role in the regulation of adaptive
immune responses. Our results indicate that such studies should
involve both purified phages and phage-generated bacterial
lysates because these two types of preparations can have different
effects on DCs.
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